デフォルト表紙
市場調査レポート
商品コード
1623734

除細動器の市場規模、シェア、成長分析、タイプ別、最終用途別、地域別 - 産業予測、2025~2032年

Cardioverter Defibrillator Device Market Size, Share, Growth Analysis, By Type (Implantable Cardioverter Defibrillators, External Cardioverter Defibrillators), By End Use (Hospitals, Pre-Hospital), By Region - Industry Forecast 2025-2032


出版日
発行
SkyQuest
ページ情報
英文 224 Pages
納期
3~5営業日
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=152.96円
除細動器の市場規模、シェア、成長分析、タイプ別、最終用途別、地域別 - 産業予測、2025~2032年
出版日: 2024年12月25日
発行: SkyQuest
ページ情報: 英文 224 Pages
納期: 3~5営業日
GIIご利用のメリット
  • 全表示
  • 概要
  • 目次
概要

除細動器の世界市場規模は2023年に151億米ドルと評価され、2024年の161億7,000万米ドルから2032年には280億米ドルに成長し、予測期間(2025-2032年)のCAGRは7.1%で成長する見通しです。

世界の除細動器市場は、製品技術の進歩、一般市民の意識の高まり、突然の心停止の発生件数の増加によって大きく成長する見通しです。その要因としては、喫煙、座りがちな生活、肥満などを特徴とする不健康なライフスタイルが挙げられます。中国、インド、ブラジルなどの新興市場では心停止症例の増加が顕著であり、市場拡大をさらに促進しています。心血管系疾患と闘うためのヘルスケア機関による政府の取り組みや努力も、こうした救命デバイスの需要を促進する上で重要な役割を果たしています。これらの要素が相まって、効果的な心臓救急ソリューションへのニーズが世界的に高まり続ける中、除細動器市場の堅調な見通しが裏付けられています。

目次

イントロダクション

  • 調査の目的
  • 調査範囲
  • 定義

調査手法

  • 情報調達
  • 二次データと一次データの方法
  • 市場規模予測
  • 市場の前提条件と制限

エグゼクティブサマリー

  • 世界市場の見通し
  • 供給と需要の動向分析
  • セグメント別機会分析

市場力学と見通し

  • 市場概要
  • 市場規模
  • 市場力学
    • 促進要因と機会
    • 抑制要因と課題
  • ポーターの分析

主な市場の考察

  • 重要成功要因
  • 競合の程度
  • 主な投資機会
  • 市場エコシステム
  • 市場の魅力指数(2024年)
  • PESTEL分析
  • マクロ経済指標
  • バリューチェーン分析
  • 価格分析
  • 規制分析

除細動器市場規模:タイプ別

  • 市場概要
  • 植込み型除細動器
  • 体外式除細動器

除細動器市場規模:最終用途別

  • 市場概要
  • 病院
  • 入院前
  • 公共アクセス市場
  • 代替ケア
  • その他

除細動器市場規模

  • 北米
    • 米国
    • カナダ
  • 欧州
    • ドイツ
    • スペイン
    • フランス
    • 英国
    • イタリア
    • その他欧州地域
  • アジア太平洋地域
    • 中国
    • インド
    • 日本
    • 韓国
    • その他アジア太平洋地域
  • ラテンアメリカ
    • ブラジル
    • その他ラテンアメリカ地域
  • 中東・アフリカ
    • GCC諸国
    • 南アフリカ
    • その他中東・アフリカ

競合情報

  • 上位5社の比較
  • 主要企業の市場ポジショニング(2024年)
  • 主な市場企業が採用した戦略
  • 市場の最近の動向
  • 企業の市場シェア分析(2024年)
  • 主要企業の企業プロファイル
    • 会社概要
    • 製品ポートフォリオ分析
    • セグメント別シェア分析
  • 収益の前年比比較(2022-2024)

主要企業プロファイル

  • Medtronic PLC
  • Abbott Laboratories
  • Boston Scientific Corporation
  • BIOTRONIK SE & Co. KG
  • LivaNova PLC
  • Stryker Corporation
  • Koninklijke Philips N.V.
  • Cardiac Science Corporation
  • Zoll Medical Corporation
  • Nihon Kohden Corporation
  • Schiller AG
  • Fukuda Denshi Co.
  • Mediana Co., Ltd.
  • Defibtech LLC
  • Physio-Control(Stryker Corporation)

結論と推奨事項

目次
Product Code: SQMIG35A2207

Global Cardioverter Defibrillator Device Market size was valued at USD 15.1 billion in 2023 and is poised to grow from USD 16.17 billion in 2024 to USD 28 billion by 2032, growing at a CAGR of 7.1% during the forecast period (2025-2032).

The global cardioverter defibrillator market is poised for significant growth driven by advancements in product technology, heightened public awareness, and rising incidences of sudden cardiac arrest. Contributing factors include unhealthy lifestyles characterized by smoking, sedentary habits, and obesity. Emerging markets such as China, India, and Brazil are experiencing a notable increase in cardiac arrest cases, further propelling market expansion. Government initiatives and efforts by healthcare organizations to combat cardiovascular diseases are also playing a crucial role in driving demand for these life-saving devices. Together, these elements underscore a robust market outlook for cardioverter defibrillators as the need for effective cardiac emergency solutions continues to grow globally.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Cardioverter Defibrillator Device market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Cardioverter Defibrillator Device Market Segmental Analysis

Global Cardioverter Defibrillator Device Market is segmented by type, end use and region. Based on type, the market is segmented into implantable cardioverter defibrillators and external cardioverter defibrillators. Based on end use, the market is segmented into hospitals, pre-hospital, public access market, alternative care and others. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Global Cardioverter Defibrillator Device Market

The global Cardioverter Defibrillator Device market is significantly driven by technological advancements in these life-saving devices, leading to improvements in cost-effectiveness, compactness, and user-friendliness. Innovations such as automated external defibrillators (AEDs) and implantable cardioverter defibrillators (ICDs) have enhanced their efficacy in managing cardiac emergencies. With proper training, laypersons can operate these devices with ease, making them more accessible in critical situations. Additionally, the rising incidence of cardiovascular conditions, including arrhythmias and heart failure, is fueling market demand, as noted by the World Health Organization, which identifies cardiovascular diseases as a leading global cause of mortality.

Restraints in the Global Cardioverter Defibrillator Device Market

The global cardioverter defibrillator device market faces significant restraints that hinder its growth potential. One primary challenge is the high cost associated with these devices, which can be prohibitive for patients from low-income backgrounds, potentially limiting their access to essential cardiac care. Moreover, the financial constraints faced by healthcare systems may further restrict the adoption rates of these vital devices in the future. Additionally, a shortage of skilled professionals, including electrophysiologists, cardiologists, and cardiac surgeons, exacerbates the situation, as the lack of expertise could lead to decreased utilization of heart defibrillators, ultimately impacting market expansion.

Market Trends of the Global Cardioverter Defibrillator Device Market

The Global Cardioverter Defibrillator Device market is witnessing a significant uptrend driven by the rise of smart pacemaker technology. These advanced devices enhance patient monitoring by detecting even subtle cardiac irregularities, promptly correcting them and providing real-time alerts to both patients and healthcare providers. This innovation not only improves patient outcomes but also contributes to decreasing mortality rates associated with cardiac issues. As healthcare systems increasingly embrace digital health solutions, the demand for smart pacemakers is expected to surge, propelling growth in the cardioverter defibrillator sector. Consequently, market players are focusing on technological advancements to meet evolving consumer needs.

Table of Contents

Introduction

  • Objectives of the Study
  • Scope of the Report
  • Definitions

Research Methodology

  • Information Procurement
  • Secondary & Primary Data Methods
  • Market Size Estimation
  • Market Assumptions & Limitations

Executive Summary

  • Global Market Outlook
  • Supply & Demand Trend Analysis
  • Segmental Opportunity Analysis

Market Dynamics & Outlook

  • Market Overview
  • Market Size
  • Market Dynamics
    • Drivers & Opportunities
    • Restraints & Challenges
  • Porters Analysis
    • Competitive rivalry
    • Threat of substitute
    • Bargaining power of buyers
    • Threat of new entrants
    • Bargaining power of suppliers

Key Market Insights

  • Key Success Factors
  • Degree of Competition
  • Top Investment Pockets
  • Market Ecosystem
  • Market Attractiveness Index, 2024
  • PESTEL Analysis
  • Macro-Economic Indicators
  • Value Chain Analysis
  • Pricing Analysis
  • Regulatory Analysis

Global Cardioverter Defibrillator Device Market Size by Type & CAGR (2025-2032)

  • Market Overview
  • Implantable Cardioverter Defibrillators
  • External Cardioverter Defibrillators

Global Cardioverter Defibrillator Device Market Size by End Use & CAGR (2025-2032)

  • Market Overview
  • Hospitals
  • Pre-Hospital
  • Public Access Market
  • Alternative Care
  • Others

Global Cardioverter Defibrillator Device Market Size & CAGR (2025-2032)

  • North America (Type, End Use)
    • US
    • Canada
  • Europe (Type, End Use)
    • Germany
    • Spain
    • France
    • UK
    • Italy
    • Rest of Europe
  • Asia Pacific (Type, End Use)
    • China
    • India
    • Japan
    • South Korea
    • Rest of Asia-Pacific
  • Latin America (Type, End Use)
    • Brazil
    • Rest of Latin America
  • Middle East & Africa (Type, End Use)
    • GCC Countries
    • South Africa
    • Rest of Middle East & Africa

Competitive Intelligence

  • Top 5 Player Comparison
  • Market Positioning of Key Players, 2024
  • Strategies Adopted by Key Market Players
  • Recent Developments in the Market
  • Company Market Share Analysis, 2024
  • Company Profiles of All Key Players
    • Company Details
    • Product Portfolio Analysis
    • Company's Segmental Share Analysis
  • Revenue Y-O-Y Comparison (2022-2024)

Key Company Profiles

  • Medtronic PLC
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Abbott Laboratories
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Boston Scientific Corporation
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • BIOTRONIK SE & Co. KG
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • LivaNova PLC
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Stryker Corporation
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Koninklijke Philips N.V.
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Cardiac Science Corporation
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Zoll Medical Corporation
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Nihon Kohden Corporation
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Schiller AG
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Fukuda Denshi Co.
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Mediana Co., Ltd.
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Defibtech LLC
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Physio-Control (Stryker Corporation)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments

Conclusion & Recommendations